1. Lipid-Sensing High-Throughput ApoA-I Assays
- Author
-
Jeffrey W. Chisholm, Nikos Pagratis, Leanna Lagpacan, Karen Schwartz, Wanchi Fung, Katherine M. Brendza, Debi Jin, Xiaohong Liu, Anita Niedziela-Majka, Latesh Lad, Roman Sakowicz, and Magdeleine Hung
- Subjects
lipid analysis ,Apolipoprotein B ,Biochemistry ,Analytical Chemistry ,chemistry.chemical_compound ,apolipoprotein A1 ,high density lipoprotein cholesterol ,Fluorescence Resonance Energy Transfer ,polycyclic compounds ,biotinylation ,Cells, Cultured ,biology ,terbium ,ABC transporter A1 ,risk assessment ,Lipids ,Cholesterol ,radioactivity ,Biotinylation ,Molecular Medicine ,lipids (amino acids, peptides, and proteins) ,Lipoproteins, HDL ,ATP Binding Cassette Transporter 1 ,Biotechnology ,Phospholipid ,Biotin ,foam cell ,lipid ,cholesterol transport ,phospholipid transfer ,Humans ,artery wall ,Fluorescent Dyes ,Apolipoprotein A-I ,human cell ,Macrophages ,nutritional and metabolic diseases ,Atherosclerosis ,Lipid Metabolism ,High-Throughput Screening Assays ,Förster resonance energy transfer ,chemistry ,ABCA1 ,cholesterol metabolism ,biology.protein ,amino terminal sequence ,ATP-Binding Cassette Transporters ,Streptavidin ,protein determination ,Adenosine triphosphate ,high throughput screening ,Lipoprotein - Abstract
Apolipoprotein A-I (ApoA-I), a primary protein component of high-density lipoprotein (HDL), plays an important role in cholesterol metabolism mediating the formation of HDL and the efflux of cellular cholesterol from macrophage foam cells in arterial walls. Lipidation of ApoA-I is mediated by adenosine triphosphate (ATP) binding cassette A1 (ABCA1). Insufficient ABCA1 activity may lead to increased risk of atherosclerosis due to reduced HDL formation and cholesterol efflux. The standard radioactive assay for measuring cholesterol transport to ApoA-I has low throughput and poor dynamic range, and it fails to measure phospholipid transfer. We describe the development of two sensitive, nonradioactive high-throughput assays that report on the lipidation of ApoA-I: a homogeneous assay based on time-resolved fluorescence resonance energy transfer (TR-FRET) and a discontinuous assay that uses the label-free Epic platform. The TR-FRET assay employs HiLyte Fluor 647-labeled ApoA-I with N-terminal biotin bound to streptavidin-terbium. When fluorescent ApoA-I was incorporated into HDL, TR-FRET decreased proportionally to the increase in the ratio of lipids to ApoA-I, demonstrating that the assay was sensitive to the amount of lipid bound to ApoA-I. In the Epic assay, biotinylated ApoA-I was captured on a streptavidin-coated biosensor. Measured resonant wavelength shift was proportional to the amount of lipids associated with ApoA-I, indicating that the assay senses ApoA-I lipidation. © 2012 Society for Laboratory Automation and Screening.
- Published
- 2012
- Full Text
- View/download PDF